title: Uncommon syndromes and treatment manifestations of malignancy: Case 4. Periorbital edema and imatinib mesylate therapy for chronic myelogenous leukemia.
authors.affiliation: Department of Medicine and Division of Oncology, University of North Dakota School of Medicine, USA.
authors.forename: Kannan
authors.initials: K
authors.lastname: Ramar
authors.forename: Anil
authors.initials: A
authors.lastname: Potti
authors.forename: Syed A
authors.initials: SA
authors.lastname: Mehdi
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D004487:Edema / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D009916:Orbital Diseases / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate